Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belatacept conversion in renal transplant
NCT00402168Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jan 2007
- Primary completion
- Jun 2009
- Modality
- Fc-Fusion Proteins
- Countries
- 12
01
Overview
Phase 2, randomised, open-label trial of belatacept in kidney transplant, sponsored by Bristol Myers Squibb. Primary endpoint: Mean Change From Baseline in Calculated Glomerular Filtration Rate at 12 months. Started Jan 2007; status: completed.
02
Drugs
belatacept
03
Conditions
kidney transplant
Beyond the preview
Go deeper on NCT00402168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00402168.